Archives: Speakers

Francesca is an architect and urban designer with a focus on sustainable design for places and cities. Trained between Italy and the UK, she has been working in London since 2011. Francesca has been exposed to working on local and international projects at different scales, feeding her interest into different cultures, needs and objectives. She has been compelled to provide successful interpretations to the most diverse clients and end-users, whether the latter were children with special-needs, or high-end developers. On a technical level, this translated into an established track record of involvement in each stage of the design and development cycle, from master planning to detailed and construction design. Francesca is a qualified LEED AP, with a speciality in Neighbourhood Development (ND), and a BREEAM Communities Assessor.

John Downes is the Head of Facades for Lend Lease in Europe. He has 30 years’ experience in the construction industry with 25 years being directly in the façade industry.

John holds an MSc Façade Engineering from the University of Bath and is a board director of the CWCT (Centre for Window and Cladding Technology). He also sits on the CWCT technical standards committee.

John leads the Lend Lease Europe Façade Specialism Unit that support all façade related aspects of the Lend Lease business. The façade unit strives to provide fully coordinated building envelope design and delivery input to enable Lend Lease to ‘Create Better Places’.

John has recently been involved in the Lend Lease bid successes on St John’s Wood and Google.

Dr. Christian Bergmann studied architecture at the University of Stuttgart and the ETH Zurich and graduated in 2006 with a diploma. He then worked as design and project manager at UNStudio, Ben van Berkel and Caroline Bos in Amsterdam. Between 2009 and 2012 he researched and taught at the Institute for Lightweight Designing and Engineering at the University of Stuttgart. With his doctorate completed in 2013, there is a strategy that enables the development of innovation-promoting and sustainable design and construction processes in a holistic way. As a project manager at Werner Sobek Design, he was responsible, among other things, for the “Aktivhaus B10” – a Zukunftshaus in the Weissenhofsiedlung in Stuttgart. He has been Senior Architect at Hadi Teherani Architects in Hamburg since 2015, where he leads several major projects. An atmospheric aura, the emotional urgency and an ecologically sound sustainability, which is already created in the design, characterize the work of the office. The Dr. Christian Bergmann’s projects have been awarded prestigious architectural and design awards.

MATTHEW ROSENBERG is an international award-winning designer who was born and raised in Saskatoon, Canada. Rosenberg’s most recent acclamations have landed him on Forbes ‘Small Giants’ list while Inc. Magazine has named him one of the ‘Top 10 Designers Every Business Should Have On Their Radar.’ In 2012, Rosenberg returned to Los Angeles after working at MAD Architects in Beijing to launch M-Rad Inc. Rosenberg is acting CEO and Design Director at M-Rad Inc. where he leads an international team working on projects around the world. His mission is to revolutionize the architecture industry to resolve its inefficiencies by expanding the scope of the architect. In less than five years he has built a client list with the likes of Amazon, Equinox, SpaceX, Ring, Blue Bottle Coffee, Virgin Hotels, Zappos, WeWork, TopGolf, and over 50 other curated partners and clients. Rosenberg has developed projects around North America in Los Angeles, New York, San Francisco, Nashville, Las Vegas, Toronto, and Saskatoon, and has started to expand to Italy, Portugal, Taipei, and Australia.

He holds a Bachelor of Fine Arts in Studio Art (University of Saskatchewan), a Bachelor of Environmental Design in Architecture (Dalhousie University), and a Masters of Architecture (SCI-Arc) which he received alongside a Selected Thesis Award. He has also studied architecture at McGill University in Montreal and the Louvre in Paris.

In this function, Daniel is part of a global multi-functional leadership team that helps the company to engage with patients in a systematic way, and helps to build partnerships in developing solutions that better meet the existing needs. He also leads a group of colleagues in the region who play a crucial role in working towards a more collaborative approach in innovation.

Daniel De Schryver joined Johnson & Johnson in 2001 as Director Corporate Communications. In that function, he initially worked in the field of oncology. In 2006 he joined the Janssen teams working in Infectious Diseases where he helped to maintain and enhance the company’s relationships with the HIV Patient Community. Later, he built the external relationships in the field of Hepatitis C, before becoming the Global Therapeutic Area Communications Leader Infectious Diseases and Vaccines. In this function he developed world wide strategic communications and public affairs programs about infectious diseases and global public health.

Daniel has a Master in Romance Philology (Literature) and he started his career as a teacher.

After having worked in communications roles in the car industry for several years, he joined the non-profit sector and became country manager for Médecins Sans Frontières in Bosnia, Croatia and Angola. Back in Europe, he headed the Communications department for the organization. Before joining Johnson & Johnson, he worked at Burson-Marsteller as a consultant on corporate communications.

His personal interests are contemporary art and architecture, politics and meeting people.

Dirk Weber is an MD, PhD with 20+ years of Pharma Industry experience in Drug, Business and Corporate Development from executive leadership positions at Merck Serono, Novartis and Takeda and entrepreneurial experience from co-founding 2 Biotech companies leading them as Chief Medical Officer to clinical stage. Dirk has worked in early and late-stage Clinical Development, conducted successful filings, led submissions teams, has developed a regional oncology Medical Affairs organization (MSL, Medical Director) and has extensive experience in conducting Medical Affairs activities to prepare for successful commercial product launches. He has longstanding oncology drug development expertise in haemato-oncology and worked on major oncology brands for Novartis (Afinitor – Breast), Merck Serono (Erbitux – CRC) and with Takeda on ADC Adcetris (Hodgkin and non-Hodgkin Lymphomas), proteasome inhibitor Ixazomib (Multiple Myeloma) and on IO drug Mepact (Osteosarcoma). He has excellent regulatory filing and launch experience throughout career.

Pinal Patel is a Global Feasibility Lead – Oncology within Global Clinical Development Operations at Janssen: The Pharmaceutical Companies of Johnson & Johnson.  In her current role, Pinal is responsible for strategy and implementation for country selection encompassing protocol planning and patient insights.

Prior to joining Janssen, she was an Engagement Strategy Lead at Bristol-Myers Squibb where she focused on building novel, fit for purpose patient and site centric strategies to drive enrollment for clinical trials in Oncology arena.  Understanding the patient journey was at the center of it all in identifying risks and opportunities to achieve the end result.  Pinal graduated from Connecticut College, USA with a B.A. in Psychology.